title: Is It Time to Inform This Patient that Further Antineoplastic Drug Therapy Will Not Be of Clinical Value?
abstract: A woman with heavy pre-treated ovarian cancer sought consultation regarding additional treatments. The case raises the vexing question of whether there may be a time in the course of the disease process where it is most appropriate to state further anti-neoplastic therapy will not be of clinical utility.
authors.affiliation: University of Texas M.D. Anderson Cancer Center, Houston, Tex., USA.
authors.forename: Maurie
authors.initials: M
authors.lastname: Markman